Abstract
It is well established that 1-methyl-4-phenylpyridinium (MPP), the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and most of its analogs are good competitive inhibitors of monoamine oxidase A, with K i values in the micromolar range, but they inhibit monoamine oxidase B only at much higher concentrations. We report here the finding that alkyl derivatives of MPP + substituted at the 4′ position of the aromatic ring are considerably more effective reversible inhibitors of the A type enzyme, with K i values in the nanomolar range (0.075 -1.6 μM). They inhibit the B type enzyme only at 2 to 3 orders of magnitude higher concentrations (32-374 μM).
| Original language | English |
|---|---|
| Pages (from-to) | 1338-1341 |
| Number of pages | 4 |
| Journal | Biochemical and Biophysical Research Communications |
| Volume | 172 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 15 Nov 1990 |
Fingerprint
Dive into the research topics of 'A new class of powerful inhibitors of monoamine oxidase A'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver